Phosphagenics’ core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.

The technology is protected by 21 patent families; either granted/pending or submitted, covering:

• The phosphorylation process - a manufacturing process for adding phosphate to certain vitamins, nutrients and drugs.
  
  
• Compounds produced by the manufacturing process - phosphorylation can enhance the bioavailability and efficacy of active compounds. Furthermore some phosphorylated compounds can act as ‘carriers’ for other vitamins and drugs and improve their absorption orally or through the skin. Phosphagenics' technology base also extends to further chemical manipulation of these phosphorylated compounds, such as reaction with complexing agents.
  
  
• Use of the compounds - for the treatment of human diseases and ailments.

Phosphagenics' patented technology has led to the development of a number of nutraceutical and pharmaceutical products. Examples include:

• Drug Delivery
  • TPM-01 carrier
  • TPM-02 carrier
• Drug Enhancement
  • APA-01 – treatment of atherosclerosis & cholesterol reduction
  • Phospha-E^® – treatment of metabolic syndrome
  • GTP-0805 - anti-cancer agent